Marchiafava–Bignami disease
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Marchiafava–Bignami disease | |
|---|---|
| Corpus callosum | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Dementia, seizures, dysarthria, coma |
| Complications | Death |
| Onset | Typically in middle-aged to elderly individuals |
| Duration | Chronic |
| Types | Type A (acute), Type B (chronic) |
| Causes | Chronic alcoholism |
| Risks | Alcohol use disorder |
| Diagnosis | MRI, CT scan |
| Differential diagnosis | Multiple sclerosis, Wernicke's encephalopathy, central pontine myelinolysis |
| Prevention | N/A |
| Treatment | Thiamine and other vitamin supplementation, abstinence from alcohol |
| Medication | N/A |
| Prognosis | Variable; can be fatal if untreated |
| Frequency | Rare |
| Deaths | N/A |
Marchiafava–Bignami disease is a rare neurological disorder characterized by the degeneration of the corpus callosum, the thick band of nerve fibers that connects the two hemispheres of the brain. This disease is most commonly associated with chronic alcoholism and malnutrition, although it can also occur in individuals without a history of alcohol abuse.
Signs and Symptoms[edit]
The symptoms of Marchiafava–Bignami disease can vary widely but often include:
- Dementia
- Seizures
- Dysarthria (difficulty speaking)
- Hemiparesis (weakness on one side of the body)
- Ataxia (lack of muscle coordination)
- Confusion
- Coma
Pathophysiology[edit]
The exact cause of Marchiafava–Bignami disease is not well understood, but it is believed to be related to the toxic effects of alcohol and nutritional deficiencies, particularly of thiamine (vitamin B1). The disease leads to the demyelination and necrosis of the corpus callosum, which disrupts communication between the two hemispheres of the brain.
Diagnosis[edit]
Diagnosis is typically made through magnetic resonance imaging (MRI) or computed tomography (CT) scans, which can reveal lesions in the corpus callosum. Clinical history and neurological examination are also important for diagnosis.
Treatment[edit]
There is no specific treatment for Marchiafava–Bignami disease. Management focuses on addressing the underlying causes, such as alcohol cessation and nutritional support. Thiamine supplementation may be beneficial. Supportive care, including physical therapy and speech therapy, can help manage symptoms.
Prognosis[edit]
The prognosis for individuals with Marchiafava–Bignami disease varies. Some patients may recover partially or fully with appropriate treatment, while others may experience significant neurological deficits or death.
History[edit]
The disease was first described in 1903 by Italian pathologists Amico Bignami and Ettore Marchiafava, who observed the condition in chronic alcoholics.
